|
| |
Pharmaceutical intermediates |
|
| Nmn 99£¥ Beta-Nicotinamide Mononucleotide Powder |
 |
| |
|
Item
|
Specification
|
Result
|
Test Method
|
|
Active Ingredeints
|
|
NMN
|
NLT 99%
|
99.94%
|
HPLC
|
|
Physical Control
|
|
Appearance
|
Crystalline powder
|
Conform
|
Visual
|
|
Color
|
White to off-white
|
Conform
|
Visual
|
|
Odor
|
Characteristic
|
Conform
|
Organoleptic
|
|
Loss on Drying
|
NMT 0.5%
|
0.35%
|
USP<731>
|
|
Mesh size
|
100% pass 60mesh
|
Conform
|
60 mesh screen
|
|
Bulk density
|
-
|
0.30g/ml
|
In house
|
|
Tapped density
|
-
|
0.25g/ml
|
In house
|
|
Chemical Control
|
|
Total Heavy Metals
|
NMT 10ppm
|
Conform
|
USP<231>
|
|
As
|
NMT 2.0ppm
|
<0.05
|
ICP-MS
|
|
Hg
|
NMT 1.0ppm
|
<0.005
|
AAS
|
|
Cd
|
NMT 2.0ppm
|
<0.01
|
ICP-MS
|
|
Pb
|
NMT 0.5ppm
|
0.12
|
ICP-MS
|
|
Microbiological Control
|
|
Total Plate Count
|
NMT 1,000cfu/g
|
Conform
|
USP<2021>
|
|
Yeast, Mold & Fungi
|
NMT 100cfu/g
|
Conform
|
USP<2021>
|
|
E.Coli
|
Negative
|
Conform
|
USP<2022>
|
|
Staphylococcus
|
Negative
|
Negative
|
USP<2022>
|
|
Salmonella
|
Negative
|
Conform
|
USP<2022>
|
|
| |
|
